封面
市场调查报告书
商品编码
1705819

神经可塑性市场:按产品类型、按应用、按最终用户、按地区

Neuroplasticity Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球神经可塑性市场规模为 111.7 亿美元,到 2032 年将达到 615.3 亿美元,2025 年至 2032 年的复合年增长率为 27.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 111.7亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 27.60% 2032年价值预测 615.3亿美元
数字。 2025年神经可塑性市场占有率(按地区)
神经可塑性市场-IMG1

神经可塑性包括多种干预措施,包括神经反馈系统、脑刺激器、认知训练计划和其他旨在优化大脑功能和促进神经可塑性变化的疗法。

市场动态:

神经系统疾病盛行率的不断上升以及对非侵入性脑刺激技术的需求不断增长是预测期内推动全球神经可塑性市场成长的关键因素。

然而,预计在预测期内,缺乏认识、有限的研究和开发以及高成本将阻碍神经可塑性市场的成长。

本研究的主要特点

  • 本报告对全球神经可塑性市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全球神经可塑性市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球神经可塑性市场报告涵盖该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球神经可塑性市场的各种策略矩阵更轻鬆地做出决策。

目录:

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 神经系统疾病盛行率不断上升
    • 增加研发活动
    • 技术进步
    • 对非侵入性和个人化治疗的需求不断增加
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 全球神经可塑性市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球神经可塑性市场(依产品类型)

  • 基于软体的解决方案
  • 基于硬体的解决方案

6. 2020 年至 2032 年全球神经可塑性市场(按应用)

  • 中风復健
  • 创伤性脑损伤 (TBI) 康復
  • 神经退化性疾病
  • 增强学习和记忆
  • 精神疾病

7. 2020 年至 2032 年全球神经可塑性市场(依最终用户划分)

  • 医院和诊所
  • 研究机构和学术中心
  • 製药和生物技术公司
  • 其他的

8. 全球神经可塑性市场(按地区划分),2020-2032 年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第九章 竞争态势

  • NeuroSky Inc
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc
  • CogniFit
  • SharpBrains
  • Emotiv Inc
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6032

Global Neuroplasticity Market is estimated to be valued at USD 11.17 Bn in 2025 and is expected to reach USD 61.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 27.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.17 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 27.60% 2032 Value Projection: USD 61.53 Bn
Figure. Neuroplasticity Market Share (%), By Region 2025
Neuroplasticity Market - IMG1

Neuroplasticity encompasses various interventions, such as neurofeedback systems, brain stimulation devices, cognitive training programs, and other therapies designed to optimize brain function and promote neuroplastic changes.

Market Dynamics:

The increasing prevalence of neurological disorders and growing demand for non-invasive brain stimulation techniques are major factors expected to drive growth of the global neuroplasticity market during the forecast period.

However, lack of awareness, limited research and development, and high costs are expected to hamper the growth of the neuroplasticity market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global neuroplasticity market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neuroplasticity market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, SharpBrains, Emotiv Inc., BrainCo, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neuroplasticity market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroplasticity market

Detailed Segmentation:

  • By Product Type:
    • Software-Based Solutions
    • Hardware-Based Solutions
  • By Application:
    • Stroke Rehabilitation
    • Traumatic Brain Injury (TBI) Rehabilitation
    • Neurodegenerative Disorders
    • Learning and Memory Enhancement
    • Mental Health Disorders
  • By End User:
    • Hospitals and Clinics
    • Research Institutes and Academic Centers
    • Pharmaceutical and Biotechnology Companies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • NeuroSky Inc.
    • Posit Science Corporation
    • BrainHQ
    • Synaptitude Brain Health
    • Mindmaze SA
    • NeuroVigil Inc.
    • Lumosity
    • Neuronetics, Inc.
    • CogniFit
    • BrainHQ
    • SharpBrains
    • Emotiv Inc.
    • BrainCo
    • Neuroscape
    • Neuroplast BV
    • Reha Technology AG
    • Virtualware Group
    • Nexeon Medsystems Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Neuroplasticity, By Product Type
    • Market Global Neuroplasticity, By Application
    • Market Global Neuroplasticity, By End User
    • Market Global Neuroplasticity, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of neurological disorders
    • Increasing research and development activities
    • Technological advancements
    • Growing demand for non-invasive and personalized treatments
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Neuroplasticity Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neuroplasticity Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Software-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hardware-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Neuroplasticity Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Stroke Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Traumatic Brain Injury (TBI) Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Neurodegenerative Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Learning and Memory Enhancement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mental Health Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Neuroplasticity Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Research Institutes and Academic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Neuroplasticity Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • NeuroSky Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Posit Science Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainHQ
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Synaptitude Brain Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mindmaze SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NeuroVigil Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lumosity
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuronetics, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CogniFit
  • SharpBrains
  • Emotiv Inc
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc
  • Analyst Views

10. Section

  • Research Methodology
  • About us